epoxyketone tetrapeptide
Is Carfilzomib legal?
Answer
Carfilzomib is authorised or registered in 10 of the 10 registers read: United States, European Union, United Kingdom, Canada, Australia, Switzerland, Brazil, Serbia, Singapore, Turkey.
Each row is what that country's own register said on the date shown. Not legal advice.
| Country | Status | Products on the register | Register | Read |
|---|---|---|---|---|
| United States | FDA-approved | Kyprolis | Regulator FDA | 2026-10-03 |
| European Union | Authorised | Kyprolis | Regulator EMA | 2026-10-03 |
| United Kingdom | Authorised | Kyprolis (Carfilzomib) | Regulator MHRA | 2026-10-03 |
| Canada | Authorised | Kyprolis | Regulator Health Canada | 2026-10-03 |
| Australia | Registered | Kyprolis | Regulator TGA | 2026-10-03 |
| Switzerland | Authorised | Kyprolis | Regulator Swissmedic | 2026-10-03 |
| Brazil | Registado | Carfilzomibe, Karfylor, Kyprolis, Zofyserve and 1 more | Regulator ANVISA | 2026-10-03 |
| Serbia | Authorised | karfilzomib | Regulator ALIMS | 2026-09-03 |
| Singapore | Registered | Carfilzomib | Regulator HSA | 2026-09-03 |
| Turkey | Ruhsatli | Karfilzomib | Regulator TITCK | 2026-09-03 |
A country not listed has no register read yet; see the world map. EU decisions also apply in Iceland, Liechtenstein and Norway.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.